Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward Deficiency.
作者信息
Edwards Drew, Roy A Kenison, Boyett Brent, Badgaiyan Rajendra D, Thanos Panayotis K, Baron David, Hauser Mary, Badgaiyan Sampada, Brewer Raymond, Siwicki David B, Downs William, Smith David E, Blum Kenneth
机构信息
Drew Edwards & Associates, Lakeview, FL, USA.
Department of Psychiatry, Tulane University School of Medicine, New Orleans, LA, USA.
出版信息
J Addict Sci. 2020 Jan 1;6(1):1-4.
Abstract
摘要
相似文献
1
2
Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).遗传成瘾风险评分（GARS）：奖赏缺乏综合征（RDS）易感性的分子神经遗传学证据。
Mol Neurobiol. 2014 Dec;50(3):765-96. doi: 10.1007/s12035-014-8726-5. Epub 2014 May 31.
3
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.一种通过纳入遗传成瘾风险严重程度（GARS）和多巴胺稳态恢复来克服“成瘾大流行”的新型精准方法。
J Pers Med. 2021 Mar 16;11(3):212. doi: 10.3390/jpm11030212.
4
Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.奖赏缺乏综合征（RDS）神经营养疗法的神经遗传学与营养基因组学：作为分子神经生物学机制函数的临床影响
J Addict Res Ther. 2012 Nov 27;3(5):139. doi: 10.4172/2155-6105.1000139.
5
Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD).遗传成瘾风险评分（GARS）的生物技术发展以及物质使用障碍（SUD）中纳入多态性等位基因风险的选择性证据。
J Syst Integr Neurosci. 2020 Aug;6(2). doi: 10.15761/JSIN.1000221. Epub 2019 Dec 19.
6
Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systems.多巴胺在与奖赏缺乏综合征（RDS）及抗奖赏系统相关的快感缺失中的分子作用。
Front Biosci (Schol Ed). 2018 Mar 1;10(2):309-325. doi: 10.2741/s518.
7
Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility.疼痛与成瘾方面的分子遗传学检测：事实、虚构与临床应用
Addict Genet. 2015 Jul 1;2(1):1-5. doi: 10.1515/addge-2015-0001. Epub 2015 Aug 28.
8
Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?奖赏缺乏综合征（RDS）令人惊讶地具有进化性且随处可见：它是“在风中飘荡”吗？
J Pers Med. 2022 Feb 21;12(2):321. doi: 10.3390/jpm12020321.
9
A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.食物成瘾与药物成瘾的共同分子和遗传基础：通过在精神病学中纳入多巴胺激动剂疗法克服多巴胺能低下特质/状态
Psychiatr Clin North Am. 2015 Sep;38(3):419-62. doi: 10.1016/j.psc.2015.05.011.
10
DNA Epigenetics in Addiction Susceptibility.成瘾易感性中的DNA表观遗传学
Front Genet. 2022 Jan 25;13:806685. doi: 10.3389/fgene.2022.806685. eCollection 2022.
引用本文的文献
1
A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence.可乐定作为α-2A受体激动剂治疗成瘾行为的历史视角：聚焦于阿片类药物依赖
INNOSC Theranostics Pharmacol Sci. 2024;7(3). doi: 10.36922/itps.1918. Epub 2024 Jul 29.
2
Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences.应激诱导的多巴胺D2基因表观遗传甲基化的鉴定及其神经学和行为学后果。
Gene Protein Dis. 2024 Mar 29;3(1). doi: 10.36922/gpd.1966.
3
Opioid use disorder: current trends and potential treatments.阿片类药物使用障碍：当前趋势和潜在治疗方法。
Front Public Health. 2024 Jan 25;11:1274719. doi: 10.3389/fpubh.2023.1274719. eCollection 2023.
4
Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis.特邀专家意见——生物信息学与局限性指令，以助力采用遗传成瘾风险筛查并识别预测性奖赏失调：诱导多巴胺稳态所需的分析证据
Med Res Arch. 2023 Sep 14;11(8). doi: 10.18103/mra.v11i8.4211.
5
Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index.“预成瘾”严重程度指数的遗传成瘾风险与心理剖析分析
J Pers Med. 2022 Oct 27;12(11):1772. doi: 10.3390/jpm12111772.
6
"Preaddiction" construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation.“预成瘾”概念与奖赏缺乏综合征：通过多巴胺能调节异常的遗传联系。
Ann Transl Med. 2022 Nov;10(21):1181. doi: 10.21037/atm-2022-32.
7
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.一种通过纳入遗传成瘾风险严重程度（GARS）和多巴胺稳态恢复来克服“成瘾大流行”的新型精准方法。
J Pers Med. 2021 Mar 16;11(3):212. doi: 10.3390/jpm11030212.
本文引用的文献
1
Would induction of dopamine homeostasis via coupling genetic addiction risk score (GARS®) and pro-dopamine regulation benefit benzodiazepine use disorder (BUD)?通过将遗传成瘾风险评分（GARS®）与多巴胺前体调节相结合来诱导多巴胺稳态，是否对苯二氮䓬类药物使用障碍（BUD）有益？
J Syst Integr Neurosci. 2018 May 3;4. doi: 10.15761/JSIN.1000196.
2
Opioid Substitution Therapy: Achieving Harm Reduction While Searching for a Prophylactic Solution.阿片类药物替代疗法：在寻求预防性解决方案的同时实现减少伤害
Curr Pharm Biotechnol. 2019;20(3):180-182. doi: 10.2174/138920102003190422150527.
3
Understanding the Scientific Basis of Post-traumatic Stress Disorder (PTSD): Precision Behavioral Management Overrides Stigmatization.理解创伤后应激障碍（PTSD）的科学基础：精准行为管理优于污名化。
Mol Neurobiol. 2019 Nov;56(11):7836-7850. doi: 10.1007/s12035-019-1600-8. Epub 2019 May 23.
4
Dissociable dopamine dynamics for learning and motivation.学习和动机的多巴胺动态可分离。
Nature. 2019 Jun;570(7759):65-70. doi: 10.1038/s41586-019-1235-y. Epub 2019 May 22.
5
Screening, Brief Intervention, and Referral to Treatment in a Retail Pharmacy Setting: The Pharmacist's Role in Identifying and Addressing Risk of Substance Use Disorder.在零售药店环境中进行筛查、简短干预和转介治疗：药剂师在识别和处理物质使用障碍风险方面的作用。
J Addict Med. 2019 Sep/Oct;13(5):403-407. doi: 10.1097/ADM.0000000000000525.
6
Genome-Wide Association Studies of Impulsive Personality Traits (BIS-11 and UPPS-P) and Drug Experimentation in up to 22,861 Adult Research Participants Identify Loci in the and genes.对冲动人格特质（BIS-11 和 UPPS-P）和药物试验的全基因组关联研究（在多达 22861 名成年研究参与者中进行）鉴定了 和 基因中的位点。
J Neurosci. 2019 Mar 27;39(13):2562-2572. doi: 10.1523/JNEUROSCI.2662-18.2019. Epub 2019 Feb 4.
7
Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors.介绍奖赏缺乏综合征的精准成瘾管理，这一构成所有成瘾行为基础的概念。
Front Psychiatry. 2018 Nov 27;9:548. doi: 10.3389/fpsyt.2018.00548. eCollection 2018.
8
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.促多巴胺调节剂（KB220PAM）与纳曲酮联合预防阿片类物质使用障碍复发的证据分析
EC Psychol Psychiatr. 2018 Aug;7(8):564-579. Epub 2018 Jul 30.
9
Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis.推动精准成瘾管理（PAM）以应对全球阿片类药物危机。
Biomed J Sci Tech Res. 2018 Jan 7;2(2):1-4. doi: 10.26717/BJSTR.2018.02.000738.
10
Dopamine D2 receptor-mediated circuit from the central amygdala to the bed nucleus of the stria terminalis regulates impulsive behavior.中杏仁核到终纹床核的多巴胺 D2 受体介导的回路调节冲动行为。
Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):E10730-E10739. doi: 10.1073/pnas.1811664115. Epub 2018 Oct 22.
Zotero 插件